KROS Keros Therapeutics, Inc.

$11.08▼ -0.81% Healthcare Other
After hours $11.08▲ +0.00% Sep 11, 7:30 PM ET
Volume 143.8K Avg Volume (10D) 143.5K
Key Metrics & Fundamentals
Market Cap
$219.69M
P/E Ratio
4.6
Div Yield
–%
52W Range
9.69 - 22.55
% vs 50 MA
2.31%
% vs 200 MA
-18.13%
RSI-14
51.6
MACD Histogram
-0.0100
Beta (1Y vs SPY)
1.05
Free Cash Flow
-$20.58M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$32.82M
COGS
–
Operating Exp
$30.94M
Operating Income
-$30.94M
EBIT
-$30.94M
Pretax Income
-$28.71M
Net Income
-$28.71M
EPS (Diluted)
-1.45
Price & Volume History
Loading chart…
Recent News
Keros Therapeutics Approves $5 Million Share Buyback
MT Newswires · Sep 8, 2026 8:21 PM
Keros Therapeutics Announces $5 Million Share Repurchase Authorization
GlobeNewswire · Sep 8, 2026 8:01 PM
Why Is Keros Therapeutics (KROS) Up 8% Since Last Earnings Report?
Zacks · Sep 2, 2026 3:30 PM
KROS $20M Takeda Milestone Adds Cash but Revenue Visibility Stays Weak
Zacks · Aug 24, 2026 4:53 PM
Should You Buy KROS Stock as Pipeline Promise Meets Revenue Risk?
Zacks · Aug 24, 2026 4:51 PM
Can Keros Therapeutics (KROS)’s $20M Takeda Pharmaceutical Company Limited (TAK) Milestone Unlock a Billion-Dollar Opportunity?
Insider Monkey · Aug 14, 2026 11:37 PM
KROS Q2 Earnings Miss as Revenues Fall to Zero, Pipeline in Focus
Zacks · Aug 4, 2026 2:43 PM
Keros Therapeutics Reports Second Quarter 2026 Financial Results
GlobeNewswire · Aug 3, 2026 8:01 PM
Keros Therapeutics to Receive Development Milestone Payment from Partner Takeda
GlobeNewswire · Jul 30, 2026 8:01 PM
Incyte (INCY) Q2 Earnings and Revenues Top Estimates
Zacks · Jul 28, 2026 12:15 PM
Financial Overview - Income Statement Quarterly

See KROS's money flow as a full page

Social Sentiment
Avg +0.22 · 4 posts
DDDiscussionTradeKROS: it’s a micro-cap biotech but I feel like they’ll grow in the next 1-2 years
r/wallstreetbets · Feb 4, 2026
The author expresses a positive outlook for KROS, citing a 'amazing run-rate' and 'extremely cheap' status, combined with a belief in future growth.
positive +0.60
DDDiscussionKROS: it’s a micro-cap biotech but I feel like they’ll grow in the next 1-2 years
r/wallstreetbets · Feb 4, 2026
The author expresses a bullish view on KROS, citing its potential for growth despite recent setbacks.
positive +0.60
DDTradePriceTarget$KROS
r/wallstreetbets · Dec 12, 2024
The author expresses a bullish sentiment ('YOLO') and highlights positive aspects (low debt, cash flow) despite a significant drop in price.
positive +0.70
These are the stocks on my watchlist (12/12)
r/stocks · Dec 12, 2024
The post contains a direct statement about KROS's significant decline in value, indicating negative sentiment.
negative -1.00
AI Analysis

Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.

Not financial advice. All data, scores, charts, and analysis on this site are provided for informational and educational purposes only and do not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. See our Legal Notice for full details.
An unhandled error has occurred. Reload 🗙